Immunogenicity of SARS-CoV-2 vaccination in adolescents with cardiac disease
Article
[키워드] acute respiratory syndrome
Affect
Anti-spike
anti-spike antibodies
antibodies
antibody
cardiac disease
Cardiomyopathy
cellular
cellular immunity
CHD
Clinical characteristics
co-morbidities
congenital heart disease
coronavirus
coronavirus disease
COVID-19
disease
Diseases
Efficacy
eight
enrolled
evaluated
event
healthy
healthy controls
Heart diseases
heart failure
humoral
Humoral immunity
immunogenicity
injection
mRNA vaccine
myocarditis
neutralizing activities
neutralizing antibody
Neutralizing antibody titer
no correlation
no significant difference
Older
Patient
pulmonary arterial hypertension
quantiferon.
reported
SARS-CoV-2
SARS-CoV-2 vaccination
second dose
severe adverse events
single ventricle
the healthy
the patient
vaccination
[DOI] 10.1111/ped.15329 PMC 바로가기
[DOI] 10.1111/ped.15329 PMC 바로가기